3-Ethyl-4-methyl-3-pyrrolin-2-one

3-Ethyl-4-methyl-3-pyrrolin-2-one is primarily used in:

• Pharmaceutical Manufacturing: It serves as an intermediate for synthesizing glimepiride and other sulfonylurea drugs used in diabetes treatment.
• Chemical Research: The compound's unique structure makes it a subject of interest in various chemical studies, including crystallization experiments that yield co-crystals with oxidized derivatives.

The primary biological activity of 3-Ethyl-4-methyl-3-pyrrolin-2-one is its role as a precursor in the synthesis of glimepiride. This compound interacts with sulfonylurea receptor 1 on pancreatic beta cells, leading to increased insulin release. The mechanism involves:

• Binding to Receptors: The compound is metabolized into active metabolites that bind to the sulfonylurea receptor, inhibiting potassium ion efflux.
• Calcium Ion Influx: This inhibition results in cell depolarization and the opening of voltage-gated calcium channels, facilitating insulin secretion.

The stimulation of insulin release contributes to lowering blood glucose levels, making it significant in diabetes management.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.